TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $761,000 | -12.8% | 55,840 | +4.7% | 0.01% | -20.0% |
| Q3 2021 | $873,000 | -0.8% | 53,311 | +2.0% | 0.01% | -9.1% |
| Q2 2021 | $880,000 | -4.6% | 52,262 | +4.0% | 0.01% | -8.3% |
| Q1 2021 | $922,000 | -4.7% | 50,233 | -5.5% | 0.01% | -7.7% |
| Q4 2020 | $967,000 | -9.3% | 53,156 | -9.0% | 0.01% | -23.5% |
| Q3 2020 | $1,066,000 | -5.2% | 58,403 | -5.9% | 0.02% | -5.6% |
| Q2 2020 | $1,124,000 | +8.0% | 62,082 | -6.7% | 0.02% | -5.3% |
| Q1 2020 | $1,041,000 | -46.8% | 66,575 | -32.9% | 0.02% | -38.7% |
| Q4 2019 | $1,958,000 | +8.8% | 99,290 | -5.0% | 0.03% | +3.3% |
| Q3 2019 | $1,800,000 | -8.3% | 104,498 | -5.8% | 0.03% | -6.2% |
| Q2 2019 | $1,963,000 | -19.1% | 110,908 | -6.9% | 0.03% | -23.8% |
| Q1 2019 | $2,426,000 | – | 119,093 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |